Managed Market Surveyor (MMS) enrolled lives data and trends reports
Pharmacy Benefit Evaluator (PBE) & Managed Market Surveyor (MMS)
Lives data updates and trends
The dynamic and rapidly changing U.S. payer landscape makes it crucial for pharma, biotech, and med tech companies to have the most up-to-date and accurate enrollment and pharmacy benefit data. Our highly trusted and rigorously validated enrolled lives and pharmacy benefit management data delivers a comprehensive dataset curated through a survey conducted twice a year of payers and government agencies by our expert analyst team.
New PBM group purchasing organizations (GPO) lives data estimates
The Clarivate release of July 2024 PBE data in December will include the addition of PBM GPO lives estimates. This new data will show the size and influence of GPOs negotiating prescription drug rebates, including the number of lives impacted at the GPO, PBM and payer (parent and subsidiary) levels for any geographic area in the U.S.
Highlights from the upcoming July 2024 MMS data release will show the following major enrollment shifts disrupting the health insurance sector:
- MMS lives data shows volatility with large enrollment shifts
- Medicaid enrollment declined by at least 4 million over the prior six months and at least 12 million over the prior year because of states redetermining eligibility following the end of the COVID public health emergency, although some geographies are seeing Medicaid growth where states have expanded eligibility.
- Public health insurance exchange enrollment growth of at least 500,000 over the prior six months and at least 4.5 million over the previous year due to people losing Medicaid eligibility.
- Continued Medicare growth driven by aging baby boomers.
Each data purchase comes with the support and insights of our subject matter experts
- Our analyst team goes above and beyond to identify key trends and insights from the latest data. With a deep understanding of the market, they provide analysis with insights you can rely on.
- We want you to get the most out of your purchase. That’s why we provide complimentary training sessions to help you understand the data and its applications. Our subject matter experts will be available to guide you through the insights and help you make informed decisions.
How our enrollment and PBM data informs customer strategies and decision making
- Inform your payer contracting strategy. With accurate and up-to-date information on payer market share, you can make strategic decisions to optimize your market access.
- Stay ahead of the competition. Analyze the shifts and trends in enrollment to identify opportunities and grow the accessibility of your therapies or maintain your market position.
- Navigate benefit design using influence. Understand the influencers of benefit design for key accounts and markets and navigate benefit design strategies more effectively.
Don’t miss out on the opportunity to equip yourself with essential enrollment data and insights. Complete the form to start leveraging the power of MMS Enrolled Lives data and trends reports to drive your market access strategy forward. Also consider purchasing Pharmacy Benefit Evaluator (PBE), which complements MMS and provides pharmacy benefit manager to health plan affiliations data with details on relationship and contract design showing control of formulary decision making and access.
To learn more about our offering and make a purchase, fill out the form.
The MMS Enrolled Lives and PBE data release occurs twice each year: The January data point is released in June followed by the July data point released in December. Stay tuned for future updates.
Complete this form to learn more about our offering and make a purchase:
